you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Dec 07, 15:44
2010.10 -5.10 (-0.25%)
Volume
AVERAGE VOLUME
5-Day
19,057
10-Day
20,746
30-Day
14,141
9,381
  • Prev. Close

    2015.20

  • Open Price

    2015.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2010.10 (31)

NSE Live

Dec 07, 15:45
2011.50 -4.30 (-0.21%)
Volume
AVERAGE VOLUME
5-Day
2,533,650
10-Day
1,764,269
30-Day
805,383
741,387
  • Prev. Close

    2015.80

  • Open Price

    2018.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2011.50 (883)

Financials

2020 2019 2018 2017 2016
Half Yearly Results of Ipca Laboratories (in Rs. Cr.) Sep '21 Mar '21 Mar '20 Sep '19 Mar '19  
Net Sales/Income from operations 2,902.44 2,356.14 2,143.86 2,223.57 1,781.40  
Other Operating Income -- -- -- -- --  
Total Income From Operations 2,902.44 2,356.14 2,143.86 2,223.57 1,781.40  
EXPENDITURE  
Consumption of Raw Materials 808.50 787.02 721.69 709.41 560.32  
Purchase of Traded Goods 109.79 131.53 104.83 99.82 84.84  
Increase/Decrease in Stocks 56.05 -150.07 -118.05 -37.00 -76.48  
Power & Fuel -- -- -- -- --  
Employees Cost 557.28 467.83 445.60 425.19 353.07  
Depreciation 100.46 96.23 91.54 87.15 84.23  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 617.82 554.36 531.63 569.55 453.28  
P/L Before Other 652.54 469.24 366.62 369.45 322.14  
Other Income 28.68 35.56 30.93 33.76 27.21  
P/L Before Int. 681.22 504.80 397.55 403.21 349.35  
Interest 2.73 3.87 7.27 8.52 11.18  
P/L Before Exceptional Items & Tax 678.49 500.93 390.28 394.69 338.17  
Exceptional Items -- -- -- -- --  
P/L Before Tax 678.49 500.93 390.28 394.69 338.17  
Tax 136.13 89.48 65.89 66.62 68.52  
P/L After Tax from Ordinary Activities 542.36 411.45 324.39 328.07 269.65  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 542.36 411.45 324.39 328.07 269.65  
Equity Share Capital 25.37 25.37 25.27 25.27 25.27  
Reserves Excluding Revaluation Reserves -- -- -- 3,389.63 --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 42.76 32.44 25.67 25.96 --  
Diluted EPS 42.76 -- -- 25.96 --  
EPS After Extra Ordinary  
Basic EPS. 42.76 32.44 25.67 25.96 --  
Diluted EPS. 42.76 -- -- 25.96 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited